M. Obinu

发表

Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence.

G. Gessa, A. Imperato, M. Casu, 1996, European journal of pharmacology.

Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization.

G. Gessa, A. Imperato, M. Casu, 1996, European journal of pharmacology.

Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment.

G. Gessa, A. Imperato, M. Casu, 1994, European journal of pharmacology.

Strain-dependent effects of dopamine agonists on acetylcholine release in the hippocampus: An in vivo study in mice

S. Cabib, S. Puglisi‐Allegra, A. Imperato, 1996, Neuroscience.

The Antioxidant Ebselen Prevents Neurotoxicity and Clinical Symptoms in a Primate Model of Parkinson's Disease

A. Imperato, V. Blanchard, S. Moussaoui, 2000, Experimental Neurology.

Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus.

G. Gessa, A. Imperato, M. Obinu, 1993, European journal of pharmacology.

The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus

G. Biggio, G. Gessa, A. Imperato, 1994, Brain Research.

Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence

A. Imperato, V. Blanchard, S. Moussaoui, 2002, Movement disorders : official journal of the Movement Disorder Society.

Brain-selective stimulation of nicotinic receptors by TC-1734 enhances ACh transmission from frontoparietal cortex and memory in rodents

T. Rooney, M. Reibaud, M. Obinu, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice.

M. Parmentier, A. Imperato, C. Ledent, 1999, European journal of pharmacology.

TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.

G. Dunbar, M. Bencherif, G. Gatto, 2006, CNS drug reviews.

Enhancement of memory in cannabinoid CB1 receptor knock-out mice.

M. Parmentier, A. Imperato, C. Ledent, 1999, European journal of pharmacology.

Inhibition of hippocampal acetylcholine release by benzodiazepines: antagonism by flumazenil.

G. Biggio, G. Gessa, A. Imperato, 1993, European journal of pharmacology.

Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus

G. Gessa, A. Imperato, M. Obinu, 1993, Brain Research.

Gene delivery of a modified antibody to Aβ reduces progression of murine Alzheimer’s disease

G. Nabel, T. Taksir, Bailin Zhang, 2019, PloS one.

Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.

G. Gessa, A. Imperato, M. Casu, 1993, The Journal of pharmacology and experimental therapeutics.

Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo?

G. Gessa, A. Imperato, L. Dazzi, 1994, European journal of pharmacology.

In vitro and in vivo characterization of TC‐1827, a novel brain α4β2 nicotinic receptor agonist with pro‐cognitive activity

M. Bencherif, G. Gatto, L. Pradier, 2004 .

Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors.

G. Gessa, A. Imperato, M. Obinu, 1992, European journal of pharmacology.

Effects of subchronic minaprine on dopamine release in the ventral striatum and on immobility in the forced swimming test

V. Cestari, S. Cabib, A. Imperato, 1994, Neuroscience Letters.